Probiodrug
Probiodrug is a privately held biopharmaceutical company focused on the development of innovative small molecule drugs. The Company was founded in 1997 and has raised a total of $52 million in private equity. In addition, it has generated more than...Founded in 1997
Homepage: http://www.probiodrug.de
Total money raised: $74.3M
06120
Weinbergweg 22
Halle/Saale
DEU
Halle/Saale
DEU
Phone: +49 345 5559900
Updated on Jan 4, 2012
Probiodrug at CrunchBase
Konrad Glund CEOProbiodrug at CrunchBase
Kumar Srinivasan Chief business officer
Hans-Ulrich Demuth CSO
Hendrik Liebers CFO
Past
January, 2012
Probiodrug raised $20.3M in unattributed round from BB Biotech Ventures, Edmond de Rothschild Investment Partners, Life Sciences Partners, Biogen Idec New Ventures, TVM Capital, and HBM BioVentures
Probiodrug Raises €15M in Funding 
finsmes.com
November, 2009
Probiodrug raised $54M in a Series B round from BB Biotech Ventures, Edmond de Rothschild Venture Capital, Biogen Idec New Ventures, IBG Fonds, TVM Capital, HBM BioVentures, CFH, and Life Sciences Partners
Probiodrug Closes Series B Financing Round exceeding EUR 36 Million (US$54 Million) 
probiodrug.de
1997
Probiodrug was founded in 1997